Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs (STRETCh)

Allergan

Status: Withdrawn

Conditions: Muscle Spasticity

Treatments: Other: No Intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT02145650

EPI-SPAS-001

Details and patient eligibility

About

This study will examine the epidemiology (incidence and control of a disease), burden, clinical need, and treatment patterns of spasticity in patients with a diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI).

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

-Diagnosis of Cerebral Palsy (CP), Multiple Sclerosis (MS), Stroke, Spinal Cord Injury (SCI), or Traumatic Brain Injury (TBI) for a minimum of 3 months

Exclusion criteria

-Participation in a spasticity clinical trial in the past 5 years.

Trial design

0 participants in 1 patient group

All Participants

Description:

Patients with a diagnosis of CP, MS, Stroke, SCI, or TBI will be evaluated for spasticity by their healthcare provider. Patients diagnosed with spasticity requiring treatment will be enrolled in the study. There is no intervention administered in this study.

Treatment:

Other: No Intervention